Talerico, Rosa http://orcid.org/0000-0003-3934-3775
Brando, Elisa
Luzi, Lorenzo
Vedovati, Maria Cristina
Giustozzi, Michela
Verso, Melina
Di Gennaro, Leonardo
Basso, Maria
Ferretti, Antonietta
Porfidia, Angelo
De Candia, Erica
Pola, Roberto
Agnelli, Giancarlo
Becattini, Cecilia
Funding for this research was provided by:
Università Cattolica del Sacro Cuore
Article History
Received: 25 February 2024
Accepted: 24 May 2024
First Online: 28 June 2024
Declarations
:
: Rosa Talerico, Elisa Brando, Lorenzo Luzi, Maria Cristina Vedovati, Michela Giustozzi, Melina Verso, Leonardo Di Gennaro, Maria Basso, Antonietta Ferretti, Angelo Porfidia, and Roberto Pola declare no competing financial interests. Erica De Candia has received research support from Daiichi Sankyo and Viatris-Mylan. Cecilia Becattini has received lecture fees and consulting fees from Bayer Healthcare, Bristol-Myers Squibb, and Daiichi Sankyo. Giancarlo Agnelli has received honoraria for lecture and advisory board contribution from Bristol-Myers Squibb, Pfizer, Daiichi Sankyo and Anthos Therapeutics.
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of University Hospital of Perugia (protocol number 2327/14) and Fondazione Policlinico Universitario A. Gemelli IRCCS (protocol number 49904/18).
: Participants provided informed consent prior to their participation.